Literature DB >> 15979988

Expectant, medical or surgical treatment for spontaneous abortion in first trimester of pregnancy: a cost analysis.

Joyce H S You1, Tony K H Chung.   

Abstract

BACKGROUND: Misoprostol and expectant care have been shown to be acceptable alternatives to routine surgical evacuation for treatment of spontaneous abortion in the first trimester of pregnancy. The objective of this study was to analyse the cost of expectant care, misoprostol therapy and surgical evacuation.
METHODS: A decision tree was designed to simulate the clinical outcome and health care resource utilization of surgical evacuation, misoprostol and expectant care for patients presenting with uncomplicated spontaneous abortion in the first trimester of pregnancy. Clinical inputs were estimated from literature and the cost analysis was conducted from the perspective of a public health care provider in Hong Kong.
RESULTS: The base-case analysis showed that the misoprostol group (1000 US dollars per patient) was the least costly alternative, followed by the expectant care (1172 US dollars per patient) and surgical evacuation (2007 US dollars per patient). Rates of complete abortion using misoprostol and expectant care were identified as influential factors. Monte Carlo simulation (10000 cohorts) showed that the misoprostol and the expectant care groups were less costly than the surgical evacuation group 100 and 88% of the time. The misoprostol group was less costly than the expectant group 100% of the time.
CONCLUSIONS: Misoprostol therapy appears to be the least costly approach for treatment of uncomplicated spontaneous abortion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15979988     DOI: 10.1093/humrep/dei163

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  11 in total

1.  A cost-effectiveness analysis of surgical versus medical management of early pregnancy loss.

Authors:  Mary Rausch; Scott Lorch; Karine Chung; Margaret Frederick; Jun Zhang; Kurt Barnhart
Journal:  Fertil Steril       Date:  2011-12-21       Impact factor: 7.329

Review 2.  Vitamin D and assisted reproduction: should vitamin D be routinely screened and repleted prior to ART? A systematic review.

Authors:  Michelle M Pacis; Chelsea N Fortin; Shvetha M Zarek; Sunni L Mumford; James H Segars
Journal:  J Assist Reprod Genet       Date:  2014-12-30       Impact factor: 3.412

3.  Expectant Versus Surgical Management of Early Pregnancy Miscarriages- A Prospective Study.

Authors:  Reshma Sajan; Mumtaz Pulikkathodi; Abdul Vahab; Valsan Mankara Kunjitty; Hassan Sheikh Imrana
Journal:  J Clin Diagn Res       Date:  2015-10-01

4.  Cost-benefit analysis of Chlamydia trachomatis screening in pregnant women in a high burden setting in the United States.

Authors:  Jared Ditkowsky; Khushal H Shah; Margaret R Hammerschlag; Stephan Kohlhoff; Tamar A Smith-Norowitz
Journal:  BMC Infect Dis       Date:  2017-02-18       Impact factor: 3.090

5.  Medical versus surgical treatment of first trimester spontaneous abortion: A cost-minimization analysis.

Authors:  Ana M Cubo; Zandra M Soto; Ana Haro-Pérez; M Estrella Hernández Hernández; M José Doyague; José M Sayagués
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

6.  Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial).

Authors:  Joyce van den Berg; Charlotte C Hamel; Marcus P Snijders; Sjors F Coppus; Frank P Vandenbussche
Journal:  BMC Pregnancy Childbirth       Date:  2019-11-27       Impact factor: 3.007

7.  Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial.

Authors:  Charlotte Hamel; Sjors Coppus; Joyce van den Berg; Esther Hink; Jacoba van Seeters; Paul van Kesteren; Ashley Merién; Bas Torrenga; Rafli van de Laar; Josien Terwisscha van Scheltinga; Ingrid Gaugler-Senden; Peppino Graziosi; Minouche van Rumste; Ewka Nelissen; Frank Vandenbussche; Marcus Snijders
Journal:  EClinicalMedicine       Date:  2021-01-06

8.  Sublingual misoprostol versus manual vacuum aspiration for treatment of incomplete abortion in Nigeria: a randomized control study.

Authors:  Vincent Chinedu Ani; Joseph Tochukwu Enebe; Cyril Chukwudi Dim; Ngozi Regina Dim; Benjamin Chukwuma Ozumba
Journal:  Pan Afr Med J       Date:  2022-02-01

9.  Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.

Authors:  Marianne A C Verschoor; Marike Lemmers; Patrick M Bossuyt; Giuseppe C M Graziosi; Petra J Hajenius; Dave J Hendriks; Marcel A H van Hooff; Hannah S van Meurs; Brent C Opmeer; Maurits W van Tulder; Liesanne Bouwma; Ruby Catshoek; Peggy Geomini; Ellen R Klinkert; Josje Langenveld; Theodoor E Nieboer; J Marinus van der Ploeg; Celine M Radder; Taeke Spinder; Lucy F van der Voet; Ben Willem J Mol; Judith A F Huirne; Willem M Ankum
Journal:  BMC Pregnancy Childbirth       Date:  2013-05-02       Impact factor: 3.007

10.  Association study of estrogen receptor alpha gene polymorphisms with spontaneous abortion: is this a possible reason for unexplained spontaneous abortion?

Authors:  Negin Anousha; Arash Hossein-Nezhad; Firouzeh Biramijamal; Ali Rahmani; Zhila Maghbooli; Elahe Aghababaei; Shahram Nemati
Journal:  Biomed Res Int       Date:  2013-10-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.